×
Personalis Share Holder Equity 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis share holder equity from 2018 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
View More
Personalis Share Holder Equity 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis share holder equity from 2018 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$24.9B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$6.8B
Bausch Health Cos (BHC)
$2.8B
Supernus Pharmaceuticals (SUPN)
$2.1B
Amphastar Pharmaceuticals (AMPH)
$1.7B
Taysha Gene Therapies (TSHA)
$314M
Assembly Biosciences (ASMB)
$95M
Sol-Gel Technologies (SLGL)
$25M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M